We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+7.03%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$4.5B
AUM Growth
+$857M
Cap. Flow
+$670M
Cap. Flow %
14.88%
Top 10 Hldgs %
17.64%
Holding
512
New
198
Increased
109
Reduced
79
Closed
118

Top Buys

Rank Stock Value
1
AMSG
Amsurg Corp
AMSG
+$73.5M
2
RCAP
RCS CAPITAL CORPORATION CLASS A COM
RCAP
+$39.5M
3
VISN
Vistance Networks Inc
VISN
+$37.4M
4
MHK icon
Mohawk Industries
MHK
+$36.3M
5
ARMK icon
Aramark
ARMK
+$31.5M

Top Sells

Rank Stock Value
1
PF
Pinnacle Foods, Inc.
PF
+$34.3M
2
PFE icon
Pfizer
PFE
+$32.3M
3
ROK icon
Rockwell Automation
ROK
+$31.2M
4
FRX
FOREST LABORATORIES INC
FRX
+$31.1M
5
NFLX icon
Netflix
NFLX
+$28.2M

Sector Composition

Rank Sector Weight
1 Healthcare 13.99%
2 Industrials 12.65%
3 Financials 10.63%
4 Consumer Discretionary 9.16%
5 Energy 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BURL icon
326
Burlington
BURL
$23.2B
$1.59M 0.04%
+50,000
New +$1.45M
AVNR
327
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$1.57M 0.03%
+278,318
New +$1.28M
TWOU
328
DELISTED
2U Inc
TWOU
$1.56M 0.03%
3,100
-3,361
-52% -$1.41M
CNCE
329
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$1.56M 0.03%
154,247
-138,526
-47% -$1.34M
AGRX
330
DELISTED
Agile Therapeutics
AGRX
$1.55M 0.03%
+89
New +$1.29M
MGNX icon
331
MacroGenics
MGNX
$257M
$1.54M 0.03%
71,120
+9,870
+16% +$207K
AVIV
332
DELISTED
AVIV REIT INC COM STK (MD)
AVIV
$1.54M 0.03%
+54,569
New +$1.48M
SPWR
333
CALL
DELISTED
SunPower Corporation Common Stock
SPWR
$1.51M 0.03%
+56,346
New +$1.23M
TIBX
334
DELISTED
TIBCO SOFTWARE INC
TIBX
$1.51M 0.03%
74,981
-33,687
-31% -$672K
MNR
335
DELISTED
Monmouth Real Estate Investment Corp
MNR
$1.49M 0.03%
+148,396
New +$1.4M
TFM
336
DELISTED
THE FRESH MARKET, INC COM STK
TFM
$1.48M 0.03%
+44,303
New +$1.5M
PARN
337
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$1.43M 0.03%
+206,683
New +$1.59M
SPWH icon
338
Sportsman's Warehouse
SPWH
$46M
$1.4M 0.03%
+175,000
New +$1.6M
LAND
339
Gladstone Land Corp
LAND
$360M
$1.31M 0.03%
100,545
+16,553
+20% +$202K
BSFT
340
DELISTED
BroadSoft, Inc.
BSFT
$1.3M 0.03%
+49,464
New +$1.19M
TRVN
341
DELISTED
Trevena, Inc.
TRVN
$1.28M 0.03%
361
-17
-4% -$53.1K
VRNT
342
DELISTED
Verint Systems
VRNT
$1.23M 0.03%
+49,075
New +$1.15M
RCPT
343
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$1.17M 0.03%
+27,500
New +$949K
QLIK
344
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
$1.16M 0.03%
+51,453
New +$1.18M
SVRA icon
345
CALL
Savara
SVRA
$1.19B
$1.12M 0.02%
25,357
– –
TSLX icon
346
Sixth Street Specialty
TSLX
$1.81B
$1.09M 0.02%
50,000
-321,993
-87% -$6.09M
ARGS
347
DELISTED
Argos Therapeutics, Inc.
ARGS
$1.09M 0.02%
6,762
+1,033
+18% +$171K
BIOA
348
CALL
DELISTED
BioAmber Inc.
BIOA
$1.08M 0.02%
108,717
+30,232
+39% +$312K
NGNE icon
349
Neurogene
NGNE
$712M
$1.04M 0.02%
5,532
+517
+10% +$99.7K
AEM icon
350
Agnico Eagle Mines
AEM
$90.5B
$1.03M 0.02%
+27,000
New +$862K
12 13
14
15 16

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q2 2014 Portfolio in Review

As of Q2 2014, Alyeska Investment Group held 512 positions worth $4.5B, up 24% from $3.64B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Alyeska Investment Group deployed $670M of net new capital in Q2 2014, opening 198 new positions and adding to 109 existing holdings. Its largest new stake was Amsurg Corp: 1,600,000 shares worth $72.9M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Pinnacle Foods, Inc., an estimated $34.3M trimmed.

  • Alyeska Investment Group's largest Q2 2014 buy was Amsurg Corp: 1,600,000 shares worth $72.9M.
  • Alyeska Investment Group added most to Capital One in Q2 2014, an estimated $18.5M increase.
  • Alyeska Investment Group's biggest Q2 2014 reduction was Pinnacle Foods, Inc., cutting an estimated $34.3M.
  • Alyeska Investment Group fully exited Pfizer in Q2 2014, selling an estimated $32.3M.
  • Alyeska Investment Group's ten largest holdings make up 18% of its $4.5B portfolio in Q2 2014.
  • Alyeska Investment Group opened 198 new positions and closed 118 in Q2 2014.
  • Alyeska Investment Group's portfolio value rose 24% quarter-over-quarter to $4.5B.

Based on Alyeska Investment Group's 13F filing for Q2 2014, filed 14 Aug 2014.